Results 121 to 130 of about 101,287 (245)

Focused microwave irradiation-assisted synthesis of N-cyclohexyl-1,2,4-oxadiazole derivatives with antitumor activity

open access: yes, 2019
A facile synthesis of 3,5-disubstituted 1,2,4-oxadiazole derivatives under focused microwave irradiation (FMWI) is reported. Arylamidoximes 1a–i and dicyclohexylcarbodiimide (DCC) were carried out in DMF under FMWI to obtain 1,2,4-oxadiazoles 2a–i in 61 ...
Roberto Nicolete (90567)   +6 more
core   +1 more source

3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM

open access: yesPharmaceuticals
Background: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disease with global implications, necessitating effective management strategies.
Tatiana V. Zinevich   +7 more
doaj   +1 more source

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties. [PDF]

open access: yesJ Enzyme Inhib Med Chem, 2022
Stankiewicz A   +12 more
europepmc   +1 more source

The preparation and rearrangement of 3- pyridyl-4-alkyl (or aryl)-1,2,4- oxadiazole-5 (4h)-thiones

open access: yes, 1991
3-Pyridyl-4-alkyl (or aryl)-1,2,4-oxadiazole-5(4H)-thiones are prepared by the reaction of N-alkyl (or aryl) pyridine carboxamide oximes with thiophosgene.
Ağırbaş, Hikmet, Dürüst, Yaşar
core   +1 more source

Rearrangements of 1,2,4-Oxadiazole: "One Ring to Rule Them All"

open access: yes, 2017
[Figure not available: see fulltext.] 1,2,4-Oxadiazoles are heterocycles characterized by low aromaticity and the presence of a weak OâN bond and are widely studied due to their tendency to rearrange into more stable heterocyclic compounds.
Antonio Palumbo Piccionello   +5 more
core   +1 more source

New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma

open access: yesMarine Drugs
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, with limited effective therapeutic options due to late diagnosis, aggressive progression, and rapid development of drug resistance.
Camilla Pecoraro   +7 more
doaj   +1 more source

Discovery of 3-phenyl-1,2,4-oxadiazole derivatives as a new class of SARS-CoV-2 main protease inhibitors. [PDF]

open access: yesBioorg Med Chem Lett, 2023
Guo N   +9 more
europepmc   +1 more source

Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: The special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole

open access: yes, 2013
The combination of experimental (inhibition of colchicine binding) and computational (COMPARE, docking studies) data unequivocally identified diaryl 5-amino-1,2,4-oxadiazoles as potent tubulin inhibitors.
Hamel, Ernest   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy